Peptide design based on key residues involved in the interaction between the cellular prion protein (PrPᶜ) and irisin
Nathália dos Santos FariaPhD.
Exerkines are molecules released into the bloodstream by skeletal muscle in response to muscle contraction during physical exercise, exerting beneficial effects on several organs and tissues. Among these molecules, irisin is a myokine generated by the proteolytic cleavage of FNDC5 (fibronectin type III domain-containing protein 5). Previous findings suggest that irisin exerts neuroprotective effects, promoting the rescue of memory and synaptic plasticity in models of Alzheimer's disease (AD). These effects are associated with the activation of intracellular signaling pathways involved in the production of neuroprotective mediators. Irisin-induced signaling can be triggered by its interaction with receptors located at the cell surface, such as integrin αVβ5. However, other cell-surface proteins may also contribute to the modulation of the biological effects mediated by this myokine. In this context, we hypothesize that the cellular prion protein (PrPᶜ) may act as a potential receptor for irisin. Under physiological conditions, PrPᶜ participates in the modulation of intracellular signaling pathways associated with neuroprotection, including the MAPK/ERK and cAMP pathways, which have also been described as targets of irisin-induced signaling. This hypothesis is further supported by the ability of PrPᶜ to interact with proteins containing fibronectin-type domains. Considering that irisin is derived from FNDC5 and contains a fibronectin type III domain, we propose that PrPᶜ may recognize and interact with this myokine. Thus, the interaction between PrPᶜ and irisin could contribute, at least in part, to the neuroprotective effects attributed to irisin. Based on previous findings from our group suggesting the existence of an interaction interface between PrPᶜ and irisin, this study aims to propose irisin-derived peptides based on the identification of key residues involved in the interaction with the cellular prion protein. Classical Mechanics approaches, including molecular docking and molecular dynamics simulations, will be employed to identify structurally stable complexes and characterize the interaction interfaces between PrPᶜ and the proposed peptides. Subsequently, Quantum Mechanics (QM) methods will be applied to investigate the intermolecular interactions established by residues at the interface, as well as their potential involvement in charge-transfer processes. The integration of Classical and Quantum Mechanics approaches will enable a detailed structural and electronic characterization of the complexes, providing a rational basis for selecting peptide candidates with potential to interact with PrPᶜ. The results may guide future experimental studies aimed at evaluating the ability of these peptides to interact with PrPᶜ and modulate signaling pathways associated with neuroprotection.
Team: Nathália dos Santos Faria, Pedro Pascutti, Sérgio Ferreira (externo)